Riversedge Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.14M Buy
7,830
+950
+14% +$131K 0.14% 67
2026
Q2
$884K Buy
6,880
+355
+5% +$41.6K 0.12% 73
2026
Q1
$785K Buy
6,525
+313
+5% +$36.1K 0.13% 63
2025
Q4
$654K Buy
6,212
+373
+6% +$35K 0.11% 64
2025
Q3
$490K Buy
+5,839
New +$481K 0.08% 75
2024
Q4
– Sell
-2,077
Closed -$236K – 108
2024
Q3
$236K Sell
2,077
-462
-18% -$54.9K 0.05% 81
2024
Q2
$314K Sell
2,539
-78
-3% -$10K 0.08% 69
2024
Q1
$345K Buy
2,617
+133
+5% +$16.4K 0.09% 60
2023
Q4
$271K Buy
+2,484
New +$258K 0.07% 66
2023
Q3
– Sell
-1,799
Closed -$208K – 73
2023
Q2
$208K Buy
+1,799
New +$204K 0.06% 70
2023
Q1
– Sell
-1,866
Closed -$207K – 75
2022
Q4
$207K Buy
+1,866
New +$191K 0.07% 65

Other funds holding MRK

Riversedge Advisors's MRK Position: Q3 2026 in Review

Riversedge Advisors increased its Merck (MRK) stake by 14% in Q3 2026, buying an estimated $131K and bringing the position to 7,830 shares worth $1.14M. The position accounts for 0.14% of the portfolio, ranked #67.

Riversedge Advisors first reported a position in MRK in Q4 2022 and has held it in 11 quarters since. 2,492 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Riversedge Advisors held 7,830 shares of Merck worth $1.14M as of Q3 2026.
  • Riversedge Advisors bought 950 Merck shares in Q3 2026, an estimated $131K.
  • Merck made up 0.14% of Riversedge Advisors's portfolio in Q3 2026, its #67 holding.
  • Riversedge Advisors first reported a position in Merck in Q4 2022 and has held it in 11 quarters since.
  • 2,492 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Riversedge Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.